This leads to problems like shaky hands, stiff muscles, slow movement, trouble with balance, and even changes in thinking and ...

Parkinson’s disease and Lewy Body Dementia (LBD) are two serious brain diseases that affect millions of people in the United ...

A phase I/II trial showed that transplanting dopaminergic progenitors derived from induced pluripotent stem cells was safe in ...

More than 944,000 people in the UK suffer from dementia and research suggests you can reduce your chances of suffering from ...

A lot, said Parkinson's expert Alfonso Fasano, MD. Alzheimer's is the most common nerve-degrading disease, he said, citing recent dementia figures. If dementia rates continue to decline as they ...

Parkinson’s Disease is commonly known as a movement disorder that affects the nervous system. But professionals say one ...

Researchers have discovered a new biomarker for Parkinson's disease. A misfolded protein facilitates reliable diagnosis even in the early stages of Parkinson's disease in body fluids.

DelveInsight’s analysis forecasts Parkinson’s disease market growth due to the introduction of emerging therapies, expecting a rise in market size during the study period (2020–2034). The anticipated ...

Now, researchers have identified ... Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of ...

Dementia, which affects over 944,000 people in the UK, refers to conditions causing ongoing cognitive decline.

Alzheimer's pathology was common in other dementias. An Alzheimer's biomarker profile was seen in unspecified dementia, Parkinson's dementia, and frontotemporal dementia. Biomarkers indicating ...

A UCSF pilot study finds psilocybin therapy surprises, showing meaningful improvements in mood, cognition, and motor symptoms ...